Equity Research Medical Instruments & Supplies

Should You Buy The Cooper Companies, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 12/13 models active

According to the CirclFi Deep Alpha Valuation Engine, The Cooper Companies, Inc. (COO) is rated as a strong fundamental performer with a QOC score of 8.5/10. Trading at $53.27, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.

The short answer: 5 of 12 CirclFi valuation models project upside for The Cooper Companies, Inc. (COO) at $53.27 — the model consensus leans bearish, with a Quality Score of 8.5/10 and Value-Trap risk of 6/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 7 of 12 models suggest overvaluation — majority bearish
  • Quality Score: 8.5/10 — Excellent — top-tier fundamentals
  • Value Trap Risk: 6/100 — Minimal — healthy fundamentals
  • Fair Value Range: $15.53 – $93.05 (499% spread)

Bullish Models

5 / 12

Bearish Models

7 / 12

Quality Score

8.5 /10

Excellent — top-tier fundamentals

Value Trap Risk

6 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

12 /13
Active Models

Avg. confidence: 54%

What Is the Investment Case for The Cooper Companies, Inc. (COO) in 2026?

What Is the Bull Case vs the Bear Case for The Cooper Companies, Inc. (COO)?

Bull case versus bear case for The Cooper Companies, Inc. (COO) at $53.27, derived from 12 active CirclFi valuation models on 2026-09-15.
Bull case — $93.05 target (+74.7%) Bear case — $15.53 target (-70.9%)
According to the CirclFi Quality of Company (QOC) framework, The Cooper Companies, Inc.'s rating of 8.5/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $15.53 (-70.9%), suggesting that the market price embeds overly optimistic growth assumptions.
According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $93.05 (+74.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens. According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +145.5% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

How Does COO Compare to Its Medical Instruments & Supplies Peers?

WST West Pharmaceutical
8.7
NEPH Nephros, Inc.
8.4
MMSI Merit Medical System
8.7
ALGN Align Technology, In
8.4
ATR AptarGroup, Inc.
8.9
BDX Becton, Dickinson an
8.3
ICUI ICU Medical, Inc.
7.5
TFX Teleflex Incorporate
6.2

Valuation data pages: WST · NEPH · MMSI · ALGN · ATR · BDX · ICUI · TFX · DXR · ISRG · RMD

See full Medical Instruments & Supplies rankings →

Which Other Stocks Score Like COO on Quality?

Closest companies to COO’s Quality of Company score of 8.5/10, across all industries.

Why Do CirclFi’s 12 Models Disagree on COO?

Spread

499%

Fair Value Range

$15.53 – $93.05

A 499% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Regime Cross

$93.05 (+74.7%)

Most Bearish

EPV

$15.53 (-70.9%)

What Are the Biggest Risks of Buying COO Stock?

Model Disagreement

499% spread signals high variance in projections.

Bearish Consensus

7/12 models suggest overvaluation.

Macro/Sector Risk

Medical Instruments & Supplies headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View COO Data Page →

So Is The Cooper Companies, Inc. (COO) Worth Buying in 2026?

Caution dominates our read on The Cooper Companies, Inc. at $53.27. 7 of 12 models see limited upside or outright downside, with the median fair value at $36.90 (-30.7%). Quality at 8.5/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.

These are quantitative model outputs, not investment recommendations. The Cooper Companies, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About COO Stock?

Should I buy COO stock right now?

Based on CirclFi's multi-model analysis, 5 of 12 models see upside for COO at $53.27. The models are divided, which means the investment case depends heavily on your assumptions about The Cooper Companies, Inc.'s future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in The Cooper Companies, Inc.?

Key risks include: wide model disagreement (499% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.

How does COO compare to its competitors?

Among Medical Instruments & Supplies peers, COO holds a Quality Score of 8.5/10. Comparable companies include WST (QOC 8.7), NEPH (QOC 8.4), MMSI (QOC 8.7). The relative ranking helps investors identify whether COO offers better fundamental quality than alternatives in the same sector.

Is COO a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. COO's Quality Score of 8.5/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy COO at?

CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $15.53 to $93.05. At $53.27, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for COO.

View COO Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →